Recurrent UTIs — When to See a Nephrologist, Not Just a GP
Urinary tract infections are the most common bacterial infection in women affecting approximately 50% of women at some point in their lives. For most women, a UTI is an uncomfortable but straightforward episode: a burning sensation when urinating, urgency, frequency, and sometimes cloudy or smelly urine, treated with a 3 to 7 day course of antibiotics and forgotten.
But for a significant minority an estimated 20 to 30% of women who have had one UTI infections recur, repeatedly, despite repeated courses of antibiotics. And for some of these women, the recurrent infections are not simply unfortunate bad luck or inadequate antibiotic treatment. They are the visible sign of an underlying structural, functional, or metabolic problem that no antibiotic will resolve until the root cause is identified and addressed.
This post is for women with recurrent UTIs who are tired of being given the same antibiotic again and again, and who suspect correctly that something else is going on. A GP is the right first point of contact for an acute UTI. A nephrologist is the right specialist for recurrent UTIs that have not resolved with standard treatment, or that keep returning despite appropriate antibiotics, or that are associated with signs of upper urinary tract involvement (fever, loin pain, elevated creatinine).
At KIMS Secunderabad, Dr. Susmitha Chandragiri leads the investigation of recurrent UTIs in women specifically identifying the structural, functional, and metabolic factors that drive recurrence and that require specialist management.
What counts as recurrent UTI?
Recurrent urinary tract infection is defined as two or more UTIs within 6 months, or three or more within 12 months each episode confirmed by a positive urine culture, not just symptoms alone. This distinction matters: many women are repeatedly treated for presumed UTI based on symptoms and a positive urine dipstick, without confirming infection by culture. A positive urine dipstick alone particularly for nitrites and leukocytes is not sufficient to confirm bacterial UTI. Urine microscopy and culture, identifying the specific organism and its antibiotic sensitivities, is the baseline investigation for any patient with recurrent infections.
Two patterns of recurrence exist: relapse (the same organism, often the same antibiotic resistance profile, recurring within 2 weeks of completing treatment suggesting incomplete eradication) and reinfection (a different organism, or the same organism after a treatment-free interval of more than 2 weeks suggesting recolonisation from the bowel or vaginal reservoir).
Distinguishing relapse from reinfection guides the investigation relapse prompts investigation for a structural reason why the infection was not cleared, while reinfection prompts assessment of the host risk factors driving recolonisation.
Why UTIs recur — the causes a GP typically misses
Structural abnormalities of the urinary tract
The most clinically important and most frequently missed cause of recurrent UTI in women is a structural abnormality that impairs complete bladder emptying, creates a reservoir for bacteria, or provides a direct route for bacteria to reach the kidney. These require imaging — ultrasound and sometimes CT urogram — to identify:
Incomplete bladder emptying (high post-void residual volume) — Urine remaining in the bladder after voiding provides a culture medium for bacterial growth between antibiotic courses. Causes in women: cystocele (bladder prolapse causing kinking of the urethra), neurogenic bladder, urethral stricture, pelvic floor dysfunction. Measurement: post-void residual ultrasound.
Urinary tract calculi — A kidney stone in the collecting system or bladder can harbour bacteria in its interstices, making infection impossible to clear with antibiotics alone. The stone must be removed for the infection to resolve permanently.
Vesicoureteric reflux (VUR) — Abnormal backflow of urine from the bladder into the ureters during voiding. Bacteria in the bladder are flushed into the upper urinary tract with each void, causing recurrent pyelonephritis. May be identified on micturating cystourethrogram (MCUG) or nuclear cystogram. Significant reflux is managed with antibiotic prophylaxis, endoscopic injection therapy, or open surgical reimplantation depending on grade and symptoms.
Urogenital fistula — Abnormal connection between the urinary tract and adjacent structures (bladder-vaginal fistula, urethrovaginal fistula). Rare but important to identify — typically requires surgical correction.
Obstructive uropathy — A ureteric stricture, pelvic ureteric junction (PUJ) obstruction, or extrinsic ureteric compression causing stasis in the upper urinary tract.
Functional causes
Neurogenic bladder
Bladder dysfunction from neurological disease (multiple sclerosis, spinal cord injury, diabetic autonomic neuropathy, stroke) impairs coordinated bladder emptying — leaving residual urine and creating conditions for recurrent infection. The KIMS neuro-urology and urodynamics centre evaluates and manages neurogenic bladder with a combination of clean intermittent catheterisation (CIC), anticholinergic medications, and intravesical botulinum toxin where appropriate.
Pelvic floor dysfunction
Weakness or incoordination of the pelvic floor muscles impairs complete bladder emptying and alters the urethrovaginal anatomy in postmenopausal women. Pelvic floor physiotherapy, topical oestrogen (for postmenopausal vaginal atrophy), and bladder training are the first-line interventions.
Metabolic and systemic factors
Diabetes
Glycosuria (glucose in the urine) provides a growth medium for bacteria. Impaired immune function in poorly controlled diabetes reduces the ability to clear infections. Women with diabetes have a significantly higher incidence of complicated UTIs, including emphysematous pyelonephritis. Optimising blood glucose control is the most important intervention for diabetic women with recurrent UTIs — antibiotic prophylaxis alone is insufficient.
Immunosuppression
Transplant recipients, patients on long-term steroids or other immunosuppressants, and HIV-positive women have higher UTI risk and more atypical organisms. At KIMS, post-transplant UTI management is part of the standard transplant follow-up protocol.
Postmenopausal vaginal atrophy
Oestrogen deficiency after menopause causes vaginal atrophy — thinning and drying of the vaginal epithelium and urethra, with changes in the vaginal microbiome that allow uropathogenic bacteria to colonise the urogenital area more readily. Topical low-dose oestrogen (vaginal cream or pessary) restores the protective vaginal milieu and significantly reduces recurrent UTI rates in postmenopausal women — often without systemic hormonal effects.
When does a recurrent UTI cause kidney damage?
Uncomplicated lower UTI (cystitis — infection confined to the bladder) does not cause kidney damage regardless of how often it recurs. The kidneys are not involved. The misery of recurrent cystitis is real but kidney function is preserved.
Upper UTI (pyelonephritis — infection reaching the kidney) is a different matter. Recurrent pyelonephritis particularly in the context of vesicoureteric reflux, obstruction, or structural abnormality causes progressive renal scarring with each episode. Repeated episodes over years can lead to reflux nephropathy, a form of CKD that results from the cumulative scarring of multiple pyelonephritis episodes. This is why identifying the structural cause of recurrent upper UTI not just treating each episode with antibiotics is clinically important for long-term kidney health.
Fever with loin or back pain during a UTI indicates pyelonephritis upper urinary tract infection. This warrants urgent medical attention and is not manageable with the same short-course antibiotic regimen used for cystitis. Repeated episodes of pyelonephritis with fever and loin pain, particularly in a woman with recurrent infections, should prompt urgent nephrologist referral for structural investigation.
The KIMS approach to recurrent UTI investigation
At KIMS, women with recurrent UTIs receive a systematic investigation that goes beyond another prescription. We focus on identifying the root cause through comprehensive diagnostic protocols.
Detailed Clinical History
Frequency and pattern of infections, relationship to sexual activity or antibiotic use, distinction of lower vs upper tract symptoms, obstetric and gynaecological history, menopausal status, diabetes or immunosuppression.
Mid-stream Urine Culture & Sensitivity
Confirming bacterial infection, identifying the organism, and guiding antibiotic choice. Multiple cultures are reviewed to identify recurring organisms or specific resistance patterns.
Ultrasound (KUB) & Post-Void Residual
Ultrasound of the kidneys, ureters, and bladder identifies structural abnormalities, stones, and hydronephrosis. Crucially, we measure post-void residual volume to assess bladder emptying.
Renal Function Assessment (eGFR)
Testing eGFR and serum creatinine to assess baseline kidney function and detect potential CKD or reflux nephropathy in women with a long history of recurrent upper UTIs.
Advanced Imaging (CT Urogram)
Performed where ultrasound suggests structural abnormality or upper tract involvement. It identifies calculi, strictures, PUJ obstruction, or complex anatomical variants.
MCUG & Urodynamic Studies
Micturating cystourethrogram (MCUG) is used where vesicoureteric reflux is suspected, while urodynamic studies evaluate neurogenic bladder or pelvic floor dysfunction.
The most underused investigation in recurrent UTI management is post-void residual volume measurement a simple, painless, 5-minute ultrasound performed immediately after urination. A post-void residual above 100ml in a woman with recurrent UTIs identifies incomplete bladder emptying as a contributing cause. This simple investigation changes management from repeated antibiotics to treating the underlying emptying problem and is performed at every KIMS recurrent UTI evaluation.
Frequently Asked Questions — Recurrent UTIs
Recurrent UTIs despite antibiotics usually have one of four explanations. First, an underlying structural abnormality — a stone, reflux, incomplete bladder emptying — is providing a reservoir for bacteria that antibiotics clear incompletely. Second, the antibiotic used is not fully effective against the specific organism causing the infection — culture and sensitivity testing identifies this. Third, reinfection from the bowel or vaginal reservoir is occurring, particularly in postmenopausal women with vaginal atrophy. Fourth, an underlying condition — diabetes, immunosuppression, neurogenic bladder — is impairing the ability to clear infections naturally. A comprehensive investigation at KIMS identifies which of these applies to your specific situation and directs treatment accordingly.
Recurrent lower UTIs (cystitis — confined to the bladder) do not damage the kidneys regardless of frequency. Recurrent upper UTIs (pyelonephritis — infection reaching the kidney) can cause kidney scarring over time, particularly in the context of vesicoureteric reflux or structural obstruction. Each episode of pyelonephritis leaves some scarring. Repeated episodes over years can cause reflux nephropathy — a form of CKD that results from cumulative renal scarring. Women with a history of recurrent fever-associated UTIs with loin pain, particularly from childhood, should have their kidney function (eGFR) checked to identify any reflux nephropathy that may have developed silently.
Yes — in two directions. First, kidney stones can harbour bacteria in their interstices and act as a permanent reservoir for infection, making UTIs impossible to fully clear with antibiotics until the stone is removed. Second, a specific type of kidney stone — struvite or infection stones — is caused by bacteria that split urea (urea-splitting organisms such as Proteus, Klebsiella, Pseudomonas), and these stones can grow very rapidly in the context of recurrent infection. A woman with recurrent UTIs caused by Proteus or Klebsiella should have imaging to exclude a struvite stone even if she has no pain — these stones can grow to fill the entire collecting system (staghorn stones) silently.
Long-term low-dose antibiotic prophylaxis — typically trimethoprim 100mg at night or nitrofurantoin 50mg at night — is one management option for recurrent uncomplicated cystitis in women where no structural cause is identified. It reduces recurrence rates significantly in the short to medium term. However, it does not treat any underlying structural cause, carries the risk of antibiotic resistance, and is generally considered a temporary or bridging measure rather than a permanent solution. Non-antibiotic prevention strategies — topical oestrogen in postmenopausal women, cranberry extract, D-mannose, vaginal lactobacillus — have supporting evidence for some patient groups. The KIMS approach is to identify and treat the underlying cause where one exists, rather than relying on indefinite antibiotic prophylaxis.
Nephrologist referral is appropriate when: the UTI is associated with fever and loin pain on more than one occasion (suggesting upper urinary tract involvement); there are any findings on ultrasound suggesting structural kidney abnormality, hydronephrosis, or stones; serum creatinine is elevated or eGFR is below 60; the infections are with atypical organisms (Proteus, Klebsiella, Pseudomonas) or antibiotic-resistant organisms; the patient has diabetes, is immunosuppressed, or is a kidney transplant recipient; recurrence is occurring despite appropriate antibiotic prophylaxis; or the patient simply wants a systematic investigation rather than another antibiotic prescription.
Yes — postmenopausal oestrogen deficiency is one of the most common and most treatable causes of recurrent UTI in older women. Oestrogen maintains the vaginal epithelium, supports a protective lactobacillus-dominant vaginal microbiome, and keeps the urethral epithelium thick and resistant to bacterial colonisation. After menopause, oestrogen loss causes vaginal atrophy — the vaginal and urethral epithelium thin, the protective microbiome is lost, and uropathogenic bacteria colonise more readily. Topical low-dose vaginal oestrogen cream or pessary — which has minimal systemic absorption and is safe even in women who cannot take oral HRT — restores the protective local environment and significantly reduces recurrent UTI rates in postmenopausal women.
KIMS Secunderabad — Dr. Susmitha Chandragiri (consultant nephrologist with women's nephrology focus), systematic investigation beyond antibiotics including post-void residual ultrasound, CT urogram, urine culture and sensitivity, eGFR assessment, and referral to the KIMS neuro-urology and urodynamics centre where indicated. Integrated urology and nephrology — structural abnormalities identified by the KIMS urology team are managed in the same institution. NABH and NABL accredited. Aarogyasri, CGHS, EHS empanelled.